Document Preview
  • Full Text
  • Scholarly Journal

An open-label, single-arm pilot study in patients with severe plaque-type psoriasis treated with an oral anti-inflammatory agent, apremilast*

; et al.
. 
; Newbury Vol. 24, Iss. 5,  (May 2008): 1529-38.